NEW! Essilor® Stellest® lenses are clinically proven to slow myopia progression in children* 1
Essilor® Stellest® lenses are the first and only FDA market authorized spectacle lens to slow the progression of nearsightedness in children* 1
Essilor® Stellest® lenses are the first and only FDA market authorized spectacle lens to slow the progression of nearsightedness in children* 1
Choose your location
Select how many patients
Schedule an eye exam
Add to calendar
1. Essilor International, data on file (2025)
* Compared to single vision lenses. Results from a prospective, randomized, double-masked, multicenter U.S. clinical trial in myopic children aged 6–12 years at initiation of treatment.
† H.A.L.T. is an acronym for Highly Aspherical Lenslet Target and does not imply a “halt” or “stop” of myopia progression.
‡Aesthetic finish